Ric M. Procyshyn, BScPharm, MSc, PharmD, PhD(A,
B)
Kalyna Z. Bezchlibnyk-Butler, BScPhm, FCSHP
David D. Kim,
BSc, MSc, PhD(B, C)
The Editors wish to acknowledge contributions from the following chapter
co-editors:
Alasdair M. Barr, PhD(B, C) (Drugs of Abuse)
Agnieszka K. Biala, MPharm, PhD(D) (Sex-Drive Depressants)
Andrius Baskys, MD, PhD(E) (Drugs for Treatment of Dementia, Pharmacogenetic
Information for Common Psychotropic Drugs)
Vincent Dagenais-Beaulé, MSc,
PharmD(F) (Antipsychotics)
Lynda Eccott, BSc,
MScPharm(G) (Natural Health Products)
Dean Elbe, BScPharm, PharmD,
BCPP(H) (Drugs for ADHD)
Katelyn Halpape, BSP, ACPR, PharmD,
BCPP(I) (Mood Stabilizers)
Rahim Janmohamed,
BScPharm(J) (Treatment of Substance Use Disorders)
Reza Rafizadeh,
BScPharm, RPh, ACPR, BCPP(K) (Treatment of Substance Use Disorders)
Christian G. Schütz, MD, PhD, MPH, FRCPC(L) (Treatment of Substance Use Disorders)
Amy Soubolsky, BSP, MScPharm(I) (Mood Stabilizers)
Fidel
Vila-Rodriguez, MD, PhD, FRCPC, FAPA(A) (Electroconvulsive Therapy, Repetitive
Transcranial Magnetic Stimulation)
Vivian Yih, BScPharm, PharmD(M)
(Antidepressants)
Bree Zehm, PharmD(N) (Antidepressants)
Tony Zhou, PharmD, ACPR(O) (Anxiolytics, Hypnotics/Sedatives)
(A) Department of Psychiatry, University of British
Columbia, Vancouver, BC, Canada
(B) British Columbia Mental Health & Substance Use Services Research Institute,
Vancouver, BC, Canada
(C) Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, Vancouver, BC, Canada
(D) Biala & Co., Vancouver, BC, Canada
(E) Specialty Center, WesternU Health, Western University of Health Sciences, Pomona, CA, USA
(F) Department of Clinical Pharmacy, Jewish General Hospital, Lady Davis Institute for Medical Research & Faculty of Pharmacy, Université de Montréal, Montréal, QC, Canada
(G) Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada
(H) Healthy Minds Centre, BC Children's Hospital, Vancouver, BC, Canada
(I) College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada
(J) British Columbia Centre on Substance Use, Interdisciplinary Addiction Fellowship Program, Vancouver, BC, Canada
(K) Lower Mainland Pharmacy Services and Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada
(L) BC Mental Health and Substance Use Services, Provincial Health Service Authority, Vancouver, BC, Canada
(M) Fraser Health Authority Mental Health and Substance Use Tertiary Older Adult Program, Vancouver, BC, Canada
(N) Department of Pharmacy, Island Health, Victoria, BC, Canada
(O) Lower Mainland Pharmacy Services and Surrey Memorial Hospital, Surrey, BC, Canada